GLP-1 Hub Podcast
Muscle Loss on a GLP-1: What Strength and Daily Function Tell You
Dr. Carolynn Francavilla explains muscle concerns on GLP-1s, from lean-mass measurements to eating enough, accessible movement and everyday strength.
Listen to this episode
The GLP-1 Hub Podcast
Preserving muscle on a GLP-1 involves more than watching a body-composition number. Can you carry your groceries, get out of a chair and move through your day comfortably? Those questions help connect a concern about muscle loss to the abilities you want treatment to protect.
Dr. Carolynn Francavilla, a family physician who treats obesity, discusses that distinction with Ana Reisdorf. Her examples range from an active person who already lifts weights to someone who struggles to walk around the house. She also describes her own GLP Strong exercise program. The useful lesson is to assess your starting point and get appropriate support, rather than assume one reassuring percentage or workout fits everyone.
Lean mass loss is not a direct measurement of muscle loss
Francavilla points out an important problem with headlines: studies often report lean mass, while the headline calls all of it muscle. These measurements are related, but they are not interchangeable.
In the SURMOUNT-1 body-composition substudy, DXA lean mass included nonfat soft tissue, including water and organs, while bone mineral was measured separately. Among 160 participants with usable scans, about three-quarters of the weight lost was fat and one-quarter was lean mass in both the tirzepatide and placebo groups. Tirzepatide produced larger absolute losses of both.
That group average does not mean an individual lost a quarter of their weight as skeletal muscle, or that this proportion is automatically safe. The substudy did not directly measure muscle strength, and its participants were mostly middle-aged. It cannot settle how much loss is acceptable for someone who already has weakness or frailty.
Ask what a result actually measures before deciding what it means. A lean-mass change can justify a closer look at nutrition, strength and function without proving that the medicine has caused a disabling muscle disorder.
Notice which everyday movements are changing
Francavilla begins with activities that are easy to overlook when they are going well: walking to the mailbox, carrying groceries, getting into a car and using the toilet. Later, she asks about stairs, falls and whether someone has to push hard on the armrests to get out of a chair.
These are useful observations to bring to an appointment. Describe a change from your usual ability: the shopping bag feels harder to carry, a familiar flight of stairs now feels difficult, or you are avoiding a task because you feel unsteady. You do not need to perform a risky test at home to make the concern worth discussing.
The EWGSOP2 sarcopenia consensus places low muscle strength at the center of assessment. Low muscle quantity or quality helps confirm the diagnosis, and physical performance helps determine severity. A clinician may use measures such as grip strength or an appropriate chair-rise assessment.
Francavilla’s questions resemble the SARC-F screening domains. Screening can identify reasons for further assessment; it does not diagnose sarcopenia by itself or rule it out when reassuring. Weakness also has other possible causes, so do not assume that every difficult day proves muscle loss.
Her contrast between stronger, active patients and those starting with limited function explains why monitoring needs differ. It should not be read as a promise that an active person can safely lose any particular number of pounds of muscle. Your own change in function deserves attention even if you look fit or a scan seems reassuring.
A home body-composition scale cannot answer the whole question
The interview discusses an InBody device and home scales as ways to follow body composition. If you already use one, its estimate may give you something to discuss with your care team. Buying a device is not a prerequisite for asking about weakness or getting nutrition and exercise support.
Bioelectrical impedance analysis estimates muscle-related measures from electrical conductivity and prediction equations. The sarcopenia consensus explains that hydration, the device and the population used to develop its equations affect the estimate. It does not directly weigh your muscles.
Ask whether a trend is meaningful, how measurements should be compared and whether strength or clinical assessment would add more useful information. Avoid changing your food intake or prescription because one reading moved. A number that looks stable also does not erase new falls, fatigue or difficulty moving.
Low appetite still needs a workable nutrition plan
Francavilla describes patients who are pleased not to feel hungry but return to clinic feeling tired and weak after eating very little. The point is not to accuse someone of choosing poorly. A large reduction in appetite can make ordinary eating unexpectedly difficult, and the care plan needs to respond.
She suggests rethinking the idea that eating must mean a large meal. Yogurt, a smoothie or a protein drink may be more manageable for some people. Ana describes taking a regular lunch break rather than waiting indefinitely to feel hungry. These are examples to discuss, not a requirement to force food that makes you gag or follow the same meal schedule.
The 2025 joint GLP-1 nutrition advisory recognizes that reduced appetite and food aversions can make adequate protein difficult. It discusses smaller-volume, nutrient-dense foods and individualized nutrition support. Protein is important, but the rest of your food, fluid and micronutrient needs still matter.
Bring the dietitian a realistic account of what you can manage and what gets in the way. Is breakfast difficult? Do you forget to take a break? Is nausea preventing eating? An individualized plan can address those different problems without making a universal protein number or mandatory three-meal rule the measure of success.
If you truly cannot eat or keep fluids down, contact the prescriber rather than trying to solve the problem with another shake. Current Zepbound prescribing information advises clinical contact for severe or persistent gastrointestinal symptoms and prompt reporting of prolonged nausea, vomiting or diarrhea because of dehydration and kidney risks. The interview’s personal dose-splitting example is not a safe instruction to copy.
Start with accessible movement and build appropriate strength work
Francavilla recalls a patient who initially could tolerate only a minute of walking and gradually became able to do much more. That story is about starting where someone is. It does not promise the same timeline or endpoint for another person.
For someone with major joint problems, difficulty moving around the house or other limitations, she suggests physical therapy to develop a safer individualized plan. Chair-based movement may be an option. The right next step depends on why movement is difficult, rather than how closely someone can imitate an online workout.
Enjoyable walking and other activity can be valuable starting points. They do not make every type of exercise interchangeable for muscle preservation. The joint nutrition advisory emphasizes structured resistance or strength training alongside appropriate nutrition; increasing protein alone is unlikely to preserve muscle adequately without that training.
The National Institute on Aging describes aerobic, muscle-strengthening and balance activity as complementary. It recommends guidance from a clinician or physical therapist when you are unsure about a movement. A plan can progress from what is currently accessible toward the strength and balance your life requires.
Francavilla’s GLP Strong program is one commercial example discussed in the interview, not evidence that its advertised minimum guarantees preservation of muscle. Current price, content and suitability would need checking separately. A useful program should accommodate your abilities and help you progress, not require you to prove commitment through pain, dizziness or exhaustion.
Keep the plan after the first weight-loss phase
The conversation also turns to maintenance. Francavilla describes people noticing some hunger return even while their weight remains stable. Ana says hunger can be helpful because it reminds her to eat. Neither example proves how an individual prescription should change, but both challenge the idea that successful treatment must eliminate every hunger cue.
Continue discussing adequate intake, symptoms and function when the scale slows or reaches a goal. Read Holly Wyatt and Jim Hill’s conversation about weight maintenance for a broader discussion of support during that transition. Medication adjustments belong with your prescriber, not a copied step-down schedule.
For your next visit, choose a concrete concern or goal: carrying the groceries comfortably, eating enough during the workday, getting up from a chair more easily or knowing which exercise is safe to start. Ask how the team will assess it and when you will review progress. Protecting muscle is most useful when it helps you remain capable and well nourished as treatment continues.
